IS528 Novel diagnostic and therapeutic radionuclides for the development of innovative radiopharmaceuticals

por Koester, Ulli, van der Meulen, Nicholas
Publicado 2018

A Step-by-Step Guide for the Novel Radiometal Production for Medical Applications: Case Studies with (68)Ga, (44)Sc, (177)Lu and (161)Tb

por Talip, Zeynep, Favaretto, Chiara, Geistlich, Susanne, van der Meulen, Nicholas P.
Publicado 2020

New Radionuclides and Technological Advances in SPECT and PET Scanners

por van der Meulen, Nicholas P., Strobel, Klaus, Lima, Thiago Viana Miranda
Publicado 2021

Scandium and terbium radionuclides for radiotheranostics: current state of development towards clinical application

por Müller, Cristina, Domnanich, Katharina A, Umbricht, Christoph A, van der Meulen, Nicholas P
Publicado 2018

Active bone marrow S-values for the low-energy electron emitter terbium-161 compared to S-values for lutetium-177 and yttrium-90

por Hemmingsson, Jens, Svensson, Johanna, van der Meulen, Nicholas P., Müller, Cristina, Bernhardt, Peter
Publicado 2022

Preclinical in vivo application of $^{152}$Tb-DOTANOC: a radiolanthanide for PET imaging

por Müller, Cristina, Vermeulen, Christiaan, Johnston, Karl, Köster, Ulli, Schmid, Raffaella, Türler, Andreas, van der Meulen, Nicholas P
Publicado 2016

Preclinical in vivo application of (152)Tb-DOTANOC: a radiolanthanide for PET imaging

por Müller, Cristina, Vermeulen, Christiaan, Johnston, Karl, Köster, Ulli, Schmid, Raffaella, Türler, Andreas, van der Meulen, Nicholas P.
Publicado 2016

Alpha-PET with terbium-149: evidence and perspectives for radiotheragnostics

por Müller, Cristina, Vermeulen, Christiaan, Köster, Ulli, Johnston, Karl, Türler, Andreas, Schibli, Roger, van der Meulen, Nicholas P.
Publicado 2016

Study of thulium-167 cyclotron production: a potential medically-relevant radionuclide

por Renaldin, Edoardo, Dellepiane, Gaia, Braccini, Saverio, Sommerhalder, Alexander, Zhang, Hui, van der Meulen, Nicholas P., Eichler, Robert, Talip, Zeynep
Publicado 2023

Contribution of Auger/conversion electrons to renal side effects after radionuclide therapy: preclinical comparison of (161)Tb-folate and (177)Lu-folate

por Haller, Stephanie, Pellegrini, Giovanni, Vermeulen, Christiaan, van der Meulen, Nicholas P., Köster, Ulli, Bernhardt, Peter, Schibli, Roger, Müller, Cristina
Publicado 2016

(44)Sc-PSMA-617 for radiotheragnostics in tandem with (177)Lu-PSMA-617—preclinical investigations in comparison with (68)Ga-PSMA-11 and (68)Ga-PSMA-617

por Umbricht, Christoph A., Benešová, Martina, Schmid, Raffaella M., Türler, Andreas, Schibli, Roger, van der Meulen, Nicholas P., Müller, Cristina
Publicado 2017

Alpha-PET for Prostate Cancer: Preclinical investigation using 149Tb-PSMA-617

por Umbricht, Christoph A., Gracheva, Nadezda, Johnston, Karl, Schibli, Roger, van der Meulen, Nicholas P., Müller, Cristina, Bernhardt, Peter, Koster, Ulli
Publicado 2019

Alpha-PET for Prostate Cancer: Preclinical investigation using (149)Tb-PSMA-617

por Umbricht, Christoph A., Köster, Ulli, Bernhardt, Peter, Gracheva, Nadezda, Johnston, Karl, Schibli, Roger, van der Meulen, Nicholas P., Müller, Cristina
Publicado 2019

(44)Sc for labeling of DOTA- and NODAGA-functionalized peptides: preclinical in vitro and in vivo investigations

por Domnanich, Katharina A., Müller, Cristina, Farkas, Renata, Schmid, Raffaella M., Ponsard, Bernard, Schibli, Roger, Türler, Andreas, van der Meulen, Nicholas P.
Publicado 2016

Dosimetric Analysis of the Short-Ranged Particle Emitter (161)Tb for Radionuclide Therapy of Metastatic Prostate Cancer

por Bernhardt, Peter, Svensson, Johanna, Hemmingsson, Jens, van der Meulen, Nicholas P., Zeevaart, Jan Rijn, Konijnenberg, Mark W., Müller, Cristina, Kindblom, Jon
Publicado 2021

Production and characterization of no-carrier-added (161)Tb as an alternative to the clinically-applied (177)Lu for radionuclide therapy

por Gracheva, Nadezda, Müller, Cristina, Talip, Zeynep, Heinitz, Stephan, Köster, Ulli, Zeevaart, Jan Rijn, Vögele, Alexander, Schibli, Roger, van der Meulen, Nicholas P.
Publicado 2019

Fifty Shades of Scandium: Comparative Study of PET Capabilities Using Sc-43 and Sc-44 with Respect to Conventional Clinical Radionuclides

por Lima, Thiago V. M., Gnesin, Silvano, Strobel, Klaus, Pérez, Maria del Sol, Roos, Justus E., Müller, Cristina, van der Meulen, Nicholas P.
Publicado 2021

Precise activity measurements of medical radionuclides using an ionization chamber: a case study with Terbium-161

por Juget, Frédéric, Talip, Zeynep, Nedjadi, Youcef, Durán, M. Teresa, Grundler, Pascal V., Zeevaart, Jan Rijn, van der Meulen, Nicholas P., Bailat, Claude
Publicado 2022

Ytterbium-175 half-life determination

por Durán, M Teresa, Juget, Frédéric, Nedjadi, Youcef, Bochud, François, Talip, Zeynep, van der Meulen, Nicholas P, Köster, Ulli, Duchemin, Charlotte, Stora, Thierry, Bailat, Claude
Publicado 2021

(161)Tb-DOTATOC Production Using a Fully Automated Disposable Cassette System: A First Step Toward the Introduction of (161)Tb into the Clinic

por Favaretto, Chiara, Grundler, Pascal V., Talip, Zeynep, Landolt, Stefan, Sepini, Lebogang, Köster, Ulli, Müller, Cristina, Schibli, Roger, Geistlich, Susanne, van der Meulen, Nicholas P.
Publicado 2023